819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer.
Saved in:
| Title: | 819TiP COLIBRI trial (GINECO-CE108b): A multicenter, window study evaluating immune impact and safety of nivolumab in combination with ipilimumab before initial radio-chemotherapy (RTCT) treatment for locally advanced cervix cancer. |
|---|---|
| Authors: | Ray-Coquard, I.L.1 (AUTHOR), Kaminsky-Forrett, M-C.2 (AUTHOR), Joly, F.3 (AUTHOR), Montané, L.4 (AUTHOR), Bello Roufai, D.5 (AUTHOR), Savoye, A.M.6 (AUTHOR), Angelergues, A.7 (AUTHOR), Hardy-Bessard, A-C.8 (AUTHOR), Mouret Reynier, M.A.9 (AUTHOR), Deluche, E.10 (AUTHOR), Caux, C.11 (AUTHOR), Saintigny, P.12 (AUTHOR), Péré, H.13 (AUTHOR), Treilleux, I.14 (AUTHOR), Betrian, S.15 (AUTHOR), Lecuru, F.16 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS770-S770. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.1261 |
